Sign In
NewsRadar

Trophos SA

Trophos is a biopharmaceutical company committed to the discovery and development of novel therapeutic compounds to treat neurodegenerative diseases.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 

Phone:
Fax:
Web:
Contact:
 
 
Parc scientifique de Luminy
Case 931
Marseille Cedex 9 13288
France
+33 (0)491 828 282
+33 (0)491 828 289
http://www.trophos.com
Antoine Béret
+33 (0)491 828 282

Company Facts
Founded:Dec 1999
Founders:
CEO:Antoine Béret
CTO or technical lead:Rebecca Pruss
CFO or finance director:Christine Placet
Head of Sales:Stephen Harris
Head of Marketing:

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:29
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

  • Patrick Cozzone, Professor of Biophysics, Faculty of Medicine in Marseille
  • Michel Delaage
  • Bernard Majoie

    Key Customers

    Key Business Partners

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    26,126
    Tech investments
    From our Online Data Service
    16,881
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Sep 13N/AEnergy related
    Sep 13€12.6MConsumer electronics
    Sep 12€39.0MBiopharmaceuticals
    Sep 12€2.3MInternet commerce
    Sep 12€2.1MInternet services
    Sep 12€4.0MMedical devices
    Sep 12€9.0MSoftware development

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises 1m in seed funding to build tech-enabled home ...





    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.